intoxicant.wiki2catechol4school
Norepinephrine–dopamine reuptake inhibitor · Stimulant

RTI-6037-13

Also called 2-(N-tert-Butylamino)-3''-chloropentanophenone

Why a "revision used" link? Anyone can edit Wikipedia at any time, so the article you open today may not say what it said when we read it. This link opens the exact version we read on 24 October 2026, frozen as it was. It is the only way to check that every quote on this page matches its source word for word. Newer versions may correct or change things. When we re-check this page against a newer version, the edit log records it. How we cite

Overview

RTI-6037-13, also known as 3′-chloro-2-(tert-butylamino)pentanophenone, is an experimental stimulant drug from the cathinone family and a bupropion analogue; this compound is related to pyrrolidinophenone (it is an α-propylphenethylamine) which has been proposed for use as a treatment for smoking cessation and as a potential treatment for cocaine dependence.[1][2][3] WP

Drug class

Norepinephrine–dopamine reuptake inhibitor Stimulant WP

From the Wikipedia article's infobox.

Pharmacology

Pharmacodynamics

RTI-6037-13 is a central nervous system stimulant; it acts as a norepinephrine–dopamine reuptake inhibitor. It is more effective at inhibiting the dopamine transporter than bupropion and cocaine, and more effective at inhibiting the norepinephrine transporter than bupropion, but not as effective as cocaine. The binding affinities (Kᵢ) for the norepinephrine and dopamine transporters were 96 ± 20 nM and 1,171 ± 260 nM, respectively, whilst the IC₅₀ values (for catecholamine reuptake) for RTI-6037-13 were 33 ± 7 nM and 472 ± 93 nM for dopamine and norepinephrine, respectively. It had no affinity for the serotonin transporter. RTI-6037-13 is a nicotinic antagonist. It blocks nicotinic receptors; it blocks the α3β4 receptor with an IC₅₀ value of 0.70 µM (2.5 times more potent than bupropion), and is more effective than bupropion at blocking the α4β2 receptor (7.7 µM versus 12 µM for bupropion). It blocked the α4β4 receptor with an affinity of 2 µM.[1][2][3] WP

RTI-6037-13 has an ED₅₀ (half-maximal effective dose) of 15.5 mg/kg. This means that it is approximately half as potent as cocaine (7.8 mg/kg), and almost three times less potent than bupropion (5.5 mg/kg) — that is, a higher dose is required to achieve 50 per cent of its maximum effect; at the peak of its activity, RTI-6037-13 reaches 108 per cent of the maximum effect of cocaine. This shows that, in terms of its maximum stimulant potency, it is practically equivalent to cocaine (and surpasses bupropion, for which this figure is 87 per cent), RTI-6037-13 has a delayed onset of maximum effect, which occurs only 90–120 minutes after administration; RTI-6037-13 effect lasts from 210 to 480 minutes (up to 8 hours), which significantly exceeds the duration of action of cocaine (40–100 minutes) and bupropion (130–270 minutes).[1][2][3] WP

The results of a drug discrimination test in rats (the subjective effect of the substance on cocaine-induced stimulation) are known; RTI-6037-13 is approximately four times weaker than cocaine in its ability to induce similar subjective sensations, but stronger than bupropion; following administration of a 25 mg/kg dose, the overall frequency of lever presses (the rat’s behavioural activity) increased, RTI-6037-13 acted as a potent stimulant.[1][2][3] WP

Chemistry

Formula
C15H22ClNO PC
Molar mass (g/mol)
267.79 PC
IUPAC name (computed by PubChem)
2-(tert-butylamino)-1-(3-chlorophenyl)pentan-1-one PC
SMILES
CCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C PC
InChIKey
PREYWAJYVTVVPE-UHFFFAOYSA-N PC
PubChem CID
3029724
IUPAC name
2-(tert-butylamino)-1-(3-chlorophenyl)pentan-1-one WP

Mixing

For best safety practice, don't mix this drug with other stimulants.

Why: vasoconstriction, heart rate and blood pressure. PsychonautWiki says:

Quotes from PsychonautWiki, CC BY-SA 4.0.

Harm reduction information

No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.

Awaiting sourceChecked against PsychonautWiki and TripSit as each pull runs. This box is replaced as soon as a source has data.

User reports

Erowid erowid.org

Listings
Awaiting sourceExperience Vault listing and report categories.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Bluelight bluelight.org

Listings
Awaiting sourceTrip report threads and this substance's discussion forum.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Reddit reddit.com

Listings
Awaiting sourceTrip report posts and the relevant subreddits.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Pop culture

No references added yet.

Add a reference

Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.

Opens when accounts launch.

Sources

  1. Journal / agency Carroll FI, Blough BE, Mascarella SW, Navarro HA, Lukas RJ, Damaj MI. Advances in Pharmacology. 2014. doi:10.1016/B978-0-12-420118-7.00005-6
  2. Journal / agency Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. Journal of Medicinal Chemistry. November 2009. doi:10.1021/jm901189z · PMID 19821577
  3. Journal / agency Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. Journal of Medicinal Chemistry. March 2010. doi:10.1021/jm9017465 · PMID 20158204 · PMC2841507

Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.